1. Home
  2. BIO

as 03-26-2025 4:00pm EST

$
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
$
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
-
0
1
2
3
4
5
6
7
8
9
.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
%

Stocks

Industrials

Biotechnology: Laboratory Analytical Instruments

Nasdaq

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (56% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (44% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (42% of 2023 sales), Europe (31%), Asia (31%), and other (6%). Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

;SMA (50)$298.68EMA (200)$315.19O: $246.75 H: $248.28 L: $243.76 C: $245.30 −1.45 (−0.59%)Elder Ray −4.10, −8.62
Founded: 1952 Country:
United States
United States
Employees: N/A City: HERCULES
Market Cap: 9.2B IPO Year: N/A
Target Price: $415.25 AVG Volume (30 days): 395.0K
Analyst Decision: Strong Buy Number of Analysts: 4
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -65.36 EPS Growth: N/A
52 Week Low/High: $243.76 - $387.99 Next Earning Date: 05-06-2025
Revenue: $2,566,500,000 Revenue Growth: -3.92%
Revenue Growth (this year): 1.11% Revenue Growth (next year): 4.55%

BIO Daily Stock ML Predictions

SELLHOLDBUYas of 19 hours ago

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use